MELANOTAN 2 NASAL SPRAY 10MG: 100MCG PER SPRAY

Description

Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. Melanotan II (MT2) is not approved for medical use, human consumption, or as a therapeutic treatment in this context.

Product Details

• Total Peptide Content: 10mg per nasal spray unit

• Delivery Format: Metered nasal spray

• Peptide Concentration: 100mcg per spray

• Estimated Sprays per Unit: ~100 sprays (device-dependent)

• Form: Aqueous peptide solution

• Packaging: Secure, sealed, tamper-evident nasal spray bottle

• Source: High-quality lab-grade peptide, independently third-party tested

• Purity: ≥98% (peptide content verified prior to formulation)

• Note: Intended strictly for controlled laboratory and experimental research applications

Overview of Melanotan II Nasal Spray’s Research Profile

Melanotan II (MT2) is a synthetic cyclic peptide analog of α-melanocyte-stimulating hormone (α-MSH), extensively studied for its interaction with melanocortin receptors (MC1R–MC5R). In a nasal spray formulation, MT2 is utilized in research settings to explore melanocortin pathway signaling, peptide-receptor binding dynamics, and intranasal peptide delivery mechanisms.

The intranasal format allows researchers to examine non-invasive peptide administration routes and evaluate how melanocortin-active peptides interact with neuroendocrine and peripheral signaling systems. MT2 is commonly used in studies involving pigmentation signaling, neuroregulatory pathways, and melanocortin receptor selectivity.

Research Specifics

Melanotan II nasal spray has been investigated in non-clinical research for its involvement in:

• Melanocortin Receptor Signaling
  Studies examining MT2 binding activity across MC1R–MC5R receptor subtypes.

• Pigmentation Pathway Modeling
  Research into α-MSH–related signaling cascades and melanocyte activation mechanisms.

• Neuroendocrine Pathway Analysis
  Exploration of central melanocortin signaling involved in appetite, energy balance, and neuroregulation.

• Intranasal Peptide Delivery Studies
  Evaluation of nasal administration as a route for peptide transport and systemic signaling access.

• Peptide Stability & Transport Research
  Assessing aqueous peptide formulation stability and metered delivery consistency.

Key Features

• Peptide Class: α-MSH analog / melanocortin receptor agonist

• Molecular Structure: Cyclic heptapeptide

• Molecular Weight: ~1024 Da

• Delivery Method: Metered intranasal spray

• Per-Spray Output: 100mcg Melanotan II

• Total Content: 10mg per unit

• Purity: ≥98% research-grade peptide

• Laboratory Stability: Formulated for stability in aqueous solution under appropriate storage conditions

Potential Applications

Researchers may explore Melanotan II nasal spray in studies involving:

• Melanocortin receptor pathway analysis

• Pigmentation signaling research

• Neuroendocrine melanocortin modeling

• Intranasal peptide delivery system evaluation

• Peptide-receptor selectivity investigations

Specifications

This product is supplied as a sealed, tamper-evident nasal spray unit to preserve peptide integrity and dosing consistency. The metered spray mechanism ensures uniform peptide delivery per actuation. Store under recommended refrigerated conditions to maintain stability.